Trial · NCT07882420
Role of Artificial Intelligence in Breast Cancer Screening Via Mammography
NCT07882420, Not applicable, Not yet recruiting, Centre Antoine Lacassagne
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Role of Artificial Intelligence in Breast Cancer Screening Via Mammography. Trials, record NCT07882420. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882420
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Role of Artificial Intelligence in Breast Cancer Screening Via Mammography
- NCT number
- NCT07882420
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 1,222 participants, estimated
- Lead sponsor
- Centre Antoine Lacassagne
- Conditions
- Breast Cancer
- Interventions
- Transpara software
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sensitivity and specificity (diagnostic performance) of radiologist using the Transpara software | 2 years | Medical conclusion of radiologist using the Transpara software at baseline compared to radiologist's decision alone at 2 years, or the result of the biopsy (positive during the follow-up period or negative at 2 years). |
| Secondary | Rate of change in care following the use of the software Transpara by radiologist compared to the decision taken before by the radiologist alone | Baseline | Rate of change in care following the use of the software Transpara by radiologist compared to the decision taken before by the radiologist alone |
| Secondary | Diagnostic performance of radiologist alone and radiologist using the Transpara software | Baseline | Compare the diagnostic performance of the radiologist working alone and the radiologist using the software at baseline |
| Secondary | Radiologist evaluation false-positive rate obtained by radiologist using the Transpara software | Baseline | To assess the false-positive rate generated by the radiologist using the Transpara™ Incepto software |
| Secondary | Adverses events assessed by CTCAE 6.0 | 2 years | To assess adverse events associated with additional diagnostic investigations prompted by the use of the Transpara™ Incepto® software. |
| Secondary | comparaison of diagnosis performance of radiologist alone and radiologist using the Transpara software | 2 years | To compare the diagnostic performance of the Transpara™ Incepto® software with that of the radiologist alone. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882420
GET https://conductscience.org/api/trials/v1/NCT07882420/registered